Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern
Author(s) -
Lisa H. Tostanoski,
Jingyou Yu,
Noe B. Mercado,
Katherine McMahan,
Catherine Jacob-Dolan,
Amanda J. Martinot,
César Piedra-Mora,
Tochi Anioke,
Aiquan Chang,
Victoria Giffin,
David Hope,
Huahua Wan,
Esther A. Bondzie,
Shant H. Mahrokhian,
Linda Wrijil,
Katherine Bauer,
Laurent Pessaint,
Maciel Porto,
Joseph Piegols,
Andrew Faudree,
Brittany Spence,
Swagata Kar,
Fatima Amanat,
Florian Krammer,
Hanné Andersen,
Mark G. Lewis,
Frank Wegmann,
Roland Zahn,
Hanneke Schuitemaker,
Dan H. Barouch
Publication year - 2021
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.abj3789
Subject(s) - vaccination , immunity , heterologous , immunology , virology , biology , covid-19 , medicine , immune system , genetics , infectious disease (medical specialty) , disease , gene , outbreak
Immunity from prior infection or Ad26.COV2.S vaccination protected hamsters from challenge with a heterologous strain of SARS-CoV-2 5 weeks later.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom